| A Novel Blood-Based Colorectal Cancer Diagnostic Technology Using Electrical Detection of Colon Cancer Secreted Protein-2. |
31179210 |
Adv Sci (Weinh) |
| Aberrant vimentin methylation is characteristic of upper gastrointestinal pathologies. |
22315367 |
Cancer Epidemiol Biomarkers Prev |
| AGA Clinical Practice Guideline on Endoscopic Eradication Therapy of Barrett's Esophagus and Related Neoplasia. |
38763697 |
|
| Allele-specific expression of TGFBR1 in colon cancer patients. |
20705955 |
Carcinogenesis |
| Aspirin and the risk of colorectal cancer in relation to the expression of 15-hydroxyprostaglandin dehydrogenase (HPGD). |
24760190 |
Sci Transl Med |
| Cancer bypasses the lymph nodes. |
28684492 |
Science |
| Colonic 15-PGDH levels are stable across distance and time and are not perturbed by aspirin intervention. |
23625286 |
Dig Dis Sci |
| Differences in DNA methylation signatures reveal multiple pathways of progression from adenoma to colorectal cancer. |
24793120 |
Gastroenterology |
| DNMT1 stability is regulated by proteins coordinating deubiquitination and acetylation-driven ubiquitination. |
21045206 |
Sci Signal |
| Emerging paradigms for the initiation of mucin-type protein O-glycosylation by the polypeptide GalNAc transferase family of glycosyltransferases. |
21349845 |
J Biol Chem |
| Epigenomic enhancer profiling defines a signature of colon cancer. |
22499810 |
Science |
| Evaluation of Patients with an Apparent False Positive Stool DNA Test: The Role of Repeat Stool DNA Testing. |
29516325 |
Dig Dis Sci |
| Genetic variation in 15-hydroxyprostaglandin dehydrogenase and colon cancer susceptibility. |
23717544 |
PLoS One |
| Global mutational profiling of formalin-fixed human colon cancers from a pathology archive. |
22878650 |
Mod Pathol |
| Identifying DNA methylation biomarkers for non-endoscopic detection of Barrett's esophagus. |
29343623 |
Sci Transl Med |
| Inhibition of 15-hydroxyprostaglandin dehydrogenase by Helicobacter pylori in human gastric carcinogenesis. |
23430757 |
Cancer Prev Res (Phila) |
| Methylated B3GAT2 and ZNF793 Are Potential Detection Biomarkers for Barrett's Esophagus. |
26545406 |
Cancer Epidemiol Biomarkers Prev |
| Molecular Imaging of Colorectal Tumors by Targeting Colon Cancer Secreted Protein-2 (CCSP-2). |
28886423 |
Neoplasia |
| MULTICENTER, PROSPECTIVE TRIAL OF NON-ENDOSCOPIC BIOMARKER-DRIVEN DETECTION OF BARRETT'S ESOPHAGUS AND ESOPHAGEAL ADENOCARCINOMA. |
38686933 |
|
| NTRK3 is a potential tumor suppressor gene commonly inactivated by epigenetic mechanisms in colorectal cancer. |
23874207 |
PLoS Genet |
| Pandemic-Related Changes in Incidence and Mortality Rates of Gastrointestinal Cancers During 2020. |
37791616 |
|
| Patients With Esophageal Adenocarcinoma With Prior Gastroesophageal Reflux Disease Symptoms Are Similar to Those Without Gastroesophageal Reflux Disease: A Cross-Sectional Study. |
37975600 |
|
| Performance of multitarget stool DNA testing in African American patients. |
30193399 |
Cancer |
| RNA Sequencing Identifies Transcriptionally Viable Gene Fusions in Esophageal Adenocarcinomas. |
27503924 |
Cancer Res |
| Subtypes of Barrett's oesophagus and oesophageal adenocarcinoma based on genome-wide methylation analysis. |
29884612 |
Gut |
| Systems Biology Analyses Show Hyperactivation of Transforming Growth Factor-β and JNK Signaling Pathways in Esophageal Cancer. |
30768984 |
Gastroenterology |
| The microRNAs, MiR-31 and MiR-375, as candidate markers in Barrett's esophageal carcinogenesis. |
22302717 |
Genes Chromosomes Cancer |
| The molecular pathogenesis of colorectal cancer and its potential application to colorectal cancer screening. |
25492499 |
Dig Dis Sci |
| Transposon mutagenesis identifies candidate genes that cooperate with loss of transforming growth factor-beta signaling in mouse intestinal neoplasms. |
27790711 |
Int J Cancer |
